本文已被:浏览 167次 下载 132次 |
码上扫一扫! |
|
复方丹参滴丸联合西医常规治疗冠心病心绞痛的回顾性队列研究 |
刘凤敏1, 杨彤1, 郭瑞莹1, 高杉1, 李琳1, 于春泉1, 雒明池2, 杨蓉蓉1
|
1.天津中医药大学, 天津 301617;2.天津中医药大学第二附属医院消化科, 天津 300150
|
|
摘要: |
[目的] 观察复方丹参滴丸联合西医常规治疗冠心病心绞痛的临床疗效,分析其临床疗效优势。[方法] 采用回顾性队列研究方法, 收集天津市 6 家医院病案管理系统中的冠心病心绞痛患者, 采集时间为 2014 年 1 月—2022 年 6 月。将这些患者分为暴露组和非暴露组,暴露组使用复方丹参滴丸联合西医常规治疗,非暴露组单独使用西医常规治疗,两组按照 1∶1 比例进行匹配,每组各 612 例。观察两组患者住院期间心血管事件发生率、临床生化指标及颈部血管彩超。[结果] 暴露组谷草转氨酶、乳酸脱氢酶、C 反应蛋白、凝血酶时间、D-二聚体、血糖、糖化血红蛋白、肌酐、尿酸、谷丙转氨酶、总胆红素、白细胞计数、颈动脉内中膜厚度、颈动脉斑块检出率低于非暴露组,差异具有统计学意义(P<0.05)。[结论] 复方丹参滴丸联合西医常规治疗的冠心病心绞痛患者心血管事件发生率较低,凝血功能、肾功能、肝功能、血糖、血脂水平较稳定,颈动脉内中膜厚度较小,斑块发生率较低。 |
关键词: 冠心病心绞痛 复方丹参滴丸 回顾性 队列研究 |
DOI:10.11656/j.issn.1673-9043.2024.06.05 |
分类号:R541.1 |
基金项目:天津市卫生健康委、天津市中医药管理局科研项目(2021057);天津市教育委员会科研项目(2021KJ118);国家自然科学基金项目(82204142)。 |
|
Retrospective cohort study of Compound Danshen Dropping Pills combined with Western medicine in the treatment of coronary heart disease and angina pectoris |
LIU Fengmin1, YANG Tong1, GUO Ruiying1, GAO Shan1, LI Lin1, YU Chunquan1, LUO Mingchi2, YANG Rongrong1
|
1.Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2.Department of Gastroenterology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150, China
|
Abstract: |
[Objective] To observe the clinical efficacy of Compound Danshen Dropping Pills combined with conventional western medicine treatment of coronary heart disease and angina pectoris,and analyse its clinical efficacy advantages. [Methods] A retrospective cohort study,coronary heart disease and angina pectoris patients from the medical record management system of 6 hospitals in Tianjin were collected from January 2014 to June 2022. The patients were divided into exposed and non-exposed groups,the exposed group was treated with Compound Danshen Dropping Pills combined with conventional western medicine treatment,and the non-exposed group was treated with conventional western medicine treatment. The two groups were matched in a 1∶1 ratio,with 612 cases each. Observe cardiovascular events,clinical biochemical indicators and carotid artery ultrasound indices in both groups during hospitalization. [Results] Aspartate aminotransferase,lactate dehydrogenase,C reactive protein, thrombin time,D-dimer,blood glucose,glycated hemoglobin,creatinine,uric acid,alanine aminotransferase,total bilirubin,leukocyte count,carotid intima-media thickness,and carotid plaque in the exposed group were significantly lower than those of the non-exposed group,and the differences was statistically significant (P<0.05). [Conclusion] It showed that the patients with coronary heart disease and angina pectoris treated with Compound Danshen Dropping Pills and conventional western medicine treatment have lower incidence of cardiovascular events,coagulation function,renal function,liver function,blood glucose and blood lipid levels were relatively stable,carotid middle thickness was smaller,and lower incidence of plaques. |
Key words: coronary heart disease angina pectoris Compound Danshen Dropping Pill retrospective cohort study |